BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · IEX Real-Time Price · USD
2.320
+0.120 (5.45%)
At close: Apr 23, 2024, 3:59 PM
2.262
-0.058 (-2.50%)
After-hours: Apr 23, 2024, 7:50 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $37.08 million as of April 23, 2024. Its market cap has decreased by -68.47% in one year.
Market Cap
37.08M
Enterprise Value
30.83M
1-Year Change
-68.47%
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $37.08M, an increase of 42.61%. That is a compound annual growth rate of 11.88%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 37.10M | 5.40% |
Apr 22, 2024 | 35.20M | 8.98% |
Apr 19, 2024 | 32.30M | -5.83% |
Apr 18, 2024 | 34.30M | -0.58% |
Apr 17, 2024 | 34.50M | -5.22% |
Apr 16, 2024 | 36.40M | -1.89% |
Apr 15, 2024 | 37.10M | -6.78% |
Apr 12, 2024 | 39.80M | -7.01% |
Apr 11, 2024 | 42.80M | -1.83% |
Apr 10, 2024 | 43.60M | -4.18% |
Apr 9, 2024 | 45.50M | -2.78% |
Apr 8, 2024 | 46.80M | 7.59% |
Apr 5, 2024 | 43.50M | -2.47% |
Apr 4, 2024 | 44.60M | -3.04% |
Apr 3, 2024 | 46.00M | 4.78% |
Apr 2, 2024 | 43.90M | -2.88% |
Apr 1, 2024 | 45.20M | -1.09% |
Mar 28, 2024 | 45.70M | 7.03% |
Mar 27, 2024 | 42.70M | 5.17% |
Mar 26, 2024 | 40.60M | -10.77% |
Mar 25, 2024 | 45.50M | 12.90% |
Mar 22, 2024 | 40.30M | 10.71% |
Mar 21, 2024 | 36.40M | 1.68% |
Mar 20, 2024 | 35.80M | -17.32% |
Mar 19, 2024 | 43.30M | -6.48% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Viracta Therapeutics | 33.64M |
Precision Optics Corporation | 33.38M |
Cyclo Therapeutics | 33.31M |
ImmunoPrecise Antibodies | 33.16M |
IGC Pharma | 32.61M |
Achilles Therapeutics | 32.16M |
bioAffinity Technologies | 32.01M |
Spectral AI | 31.79M |